Sheets Smith Wealth Management Immunity Bio, Inc. Transaction History
Sheets Smith Wealth Management
- $828 Million
- Q2 2024
A detailed history of Sheets Smith Wealth Management transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 665,995 shares of IBRX stock, worth $2.28 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
665,995
Previous 945,720
29.58%
Holding current value
$2.28 Million
Previous $5.08 Million
17.11%
% of portfolio
0.51%
Previous 0.57%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
219Shares Held
63.4MCall Options Held
1.44MPut Options Held
4.12M-
Vanguard Group Inc Valley Forge, PA13.8MShares$47.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$39.2 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$13.4 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$5.89 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.37B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...